Comparing Surgery vs Transcatheter Valve Repair for Aortic Regurgitation

Trial ID:
IRB-25-8531
Curtiss Stinis, MD

Inclusion Criteria

Patients must:

  • Be 18 years or older with a clinical indication for aortic valve regurgitation
    Be a candidate for both transcatheter valve repair and surgical valve repair
    Meet all other eligibility criteria

Exclusion Criteria

Patients must not:

  • Have mitral or tricuspid disease considered clinically significant
    Have a life expectancy less than 2 years
    Have moderate to severe or worse right ventricular dysfunction
    Have complex coronary artery disease

Additional Info

The Trilogy THV System is indicated for valve replacement among subjects who have a guideline Class I or II indication for Grade >3+ predominant native valve aortic regurgitation and can receive either surgical or transcatheter valve therapy according to the local heart team.

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org